AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35879007 — intervention group
Group type: COMPARATOR
Intervention: Control group (no improved MWH model)
Number of subjects: 158
Study 33791930 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored gain-framed message
Number of subjects: 808
Study 33791930 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored gain-framed communication
Number of subjects: 808
Study 33791930 — intervention group
Group type: COMPARATOR
Intervention: Non-tailored message
Number of subjects: 808
Study 32434934 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed consent documents from hospitals
Number of subjects: 2480
Study 35050355 — intervention group
Group type: EXPERIMENTAL
Intervention: Urolithin A (1000 mg daily for 4 months)
Number of subjects: 66
Study 35050355 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 32928313 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% Povidone-Iodine gargle and nasal lavage, 10 ml, for 20-30 seconds, thrice daily for 6 days
Number of subjects: 50
Study 32928313 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% Hydrogen peroxide gargle and nasal lavage, 10 ml, for 20-30 seconds, thrice daily for 6 days
Number of subjects: 50
Study 32928313 — intervention group
Group type: EXPERIMENTAL
Intervention: Neem extract (Azardirachta indica) gargle and nasal lavage, 10 ml, for 20-30 seconds, thrice daily for 6 days
Number of subjects: 50
Study 32928313 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% hypertonic saline gargle and nasal lavage, 10 ml, for 20-30 seconds, thrice daily for 6 days
Number of subjects: 50
Study 32928313 — intervention group
Group type: COMPARATOR
Intervention: Distilled water gargle and nasal lavage, 10 ml, for 20-30 seconds, thrice daily for 6 days
Number of subjects: 50
Study 36167636 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron (1 mg twice daily) plus sertraline (100 mg daily initially followed by 200 mg daily after week 4)
Number of subjects: 58
Study 36167636 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus sertraline (100 mg daily initially followed by 200 mg daily after week 4)
Number of subjects: 58
Study 33315105 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg nilotinib
Number of subjects: 76
Study 33315105 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg nilotinib
Number of subjects: 76
Study 33315105 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 35072420 — intervention group
Group type: EXPERIMENTAL
Intervention: Coverage of all buccal cusps (T2)
Number of subjects: 60
Study 35072420 — intervention group
Group type: EXPERIMENTAL
Intervention: Coverage of all cusps (T6)
Number of subjects: 60
Study 35072420 — intervention group
Group type: COMPARATOR
Intervention: Other types of cuspal coverage (T1, T3, T4, T5)
Number of subjects: 60
Study 33085056 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 0
Study 33085056 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33892089 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention implemented in stepped wedge trials
Number of subjects: 0
Study 33892089 — intervention group
Group type: COMPARATOR
Intervention: Control clusters
Number of subjects: 0
Study 32886012 — intervention group
Group type: EXPERIMENTAL
Intervention: First-episode psychosis patients (FEPP)
Number of subjects: 119
Study 32886012 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenia patients (SPP)
Number of subjects: 119
Study 32886012 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (Control)
Number of subjects: 119
Study 35685610 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (2000 IU)
Number of subjects: 75
Study 35685610 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 34102649 — intervention group
Group type: EXPERIMENTAL
Intervention: Survived mass shooters with psychiatric diagnosis
Number of subjects: 35
Study 34102649 — intervention group
Group type: COMPARATOR
Intervention: Mass shooters who died
Number of subjects: 35
Study 34102649 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass shooters with psychiatric illnesses
Number of subjects: 35
Study 33009147 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid LD flap
Number of subjects: 89
Study 33009147 — intervention group
Group type: COMPARATOR
Intervention: Abdominal-based free flap
Number of subjects: 89
Study 33176756 — intervention group
Group type: EXPERIMENTAL
Intervention: Atraumatic Restorative Treatment (ART)
Number of subjects: 131
Study 33176756 — intervention group
Group type: COMPARATOR
Intervention: Hall Technique (HT)
Number of subjects: 131
Study 33176756 — intervention group
Group type: EXPERIMENTAL
Intervention: Both ART and HT
Number of subjects: 131
Study 32156175 — intervention group
Group type: EXPERIMENTAL
Intervention: IV acetaminophen
Number of subjects: 66
Study 32156175 — intervention group
Group type: COMPARATOR
Intervention: IV placebo
Number of subjects: 66
Study 32410687 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive coronary angiography (ICA)
Number of subjects: 1263
Study 32410687 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary computed tomography angiography (CTA)
Number of subjects: 1263
Study 32410687 — intervention group
Group type: EXPERIMENTAL
Intervention: Typical angina
Number of subjects: 1263
Study 32410687 — intervention group
Group type: EXPERIMENTAL
Intervention: Atypical angina
Number of subjects: 1263
Study 32410687 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-anginal chest discomfort
Number of subjects: 1263
Study 32410687 — intervention group
Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 1263
Study 32410687 — intervention group
Group type: COMPARATOR
Intervention: Obstructive CAD
Number of subjects: 1263
Study 616264954 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone tunnel impaction technique using dilators
Number of subjects: 31
Study 616264954 — intervention group
Group type: COMPARATOR
Intervention: Regular extraction bone tunnel drilling
Number of subjects: 31
Study 35655314 — intervention group
Group type: EXPERIMENTAL
Intervention: BIDI® Stick ENDS
Number of subjects: 18
Study 35655314 — intervention group
Group type: COMPARATOR
Intervention: JUUL ENDS
Number of subjects: 18
Study 33291142 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-measurement of urinary chloride
Number of subjects: 138
Study 33291142 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 138
Study 35361700 — intervention group
Group type: EXPERIMENTAL
Intervention: cTBS
Number of subjects: 120
Study 35361700 — intervention group
Group type: COMPARATOR
Intervention: 1 Hz rTMS
Number of subjects: 120
Study 35361700 — intervention group
Group type: COMPARATOR
Intervention: sham cTBS
Number of subjects: 120
Study 33399416 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline GCIPL thickness in RRMS
Number of subjects: 180
Study 33399416 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline GCIPL tertiles in RRMS
Number of subjects: 180
Study 33399416 — intervention group
Group type: COMPARATOR
Intervention: Baseline pRNFL and GCIPL thickness
Number of subjects: 180
Study 32071190 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous tibial nerve stimulation (TTNS)
Number of subjects: 208
Study 32071190 — intervention group
Group type: COMPARATOR
Intervention: Sham transcutaneous tibial nerve stimulation (sham TTNS)
Number of subjects: 208
Study 35796800 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium oxalate (Oxa-Gel BF)
Number of subjects: 74
Study 35796800 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-power laser irradiation (LL)
Number of subjects: 74
Study 35796800 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium oxalate (Oxa-Gel BF) associated with low-power laser irradiation (POLL)
Number of subjects: 74
Study 33059959 — intervention group
Group type: EXPERIMENTAL
Intervention: PopART intervention (universal home-based HIV testing, linkage to care, ART adherence, and other services)
Number of subjects: 128241
Study 33059959 — intervention group
Group type: EXPERIMENTAL
Intervention: PopART intervention
Number of subjects: 128241
Study 32281361 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with modified Xiangfu Decoction
Number of subjects: 120
Study 32281361 — intervention group
Group type: COMPARATOR
Intervention: Estazolam
Number of subjects: 120
Study 35166158 — intervention group
Group type: COMPARATOR
Intervention: Psilocybin-assisted treatment with supportive psychotherapy
Number of subjects: 27
Study 35166158 — intervention group
Group type: COMPARATOR
Intervention: Psilocybin-assisted treatment
Number of subjects: 27
Study 33770708 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended interval dosing (EID) regimen (MDI 6.1 weeks)
Number of subjects: 316
Study 33770708 — intervention group
Group type: COMPARATOR
Intervention: Standard interval dosing (SID) regimen (MDI 4.5 weeks)
Number of subjects: 316
Study 34952745 — intervention group
Group type: EXPERIMENTAL
Intervention: ED-LINC intervention
Number of subjects: 40
Study 34952745 — intervention group
Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 40
Study 33539991 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Worker Health intervention with active workstations and additional support
Number of subjects: 0
Study 33539991 — intervention group
Group type: COMPARATOR
Intervention: Usual practice control with active workstations and no additional support
Number of subjects: 0
Study 32722731 — intervention group
Group type: EXPERIMENTAL
Intervention: Biweekly yoga
Number of subjects: 3
Study 32722731 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly yoga
Number of subjects: 3
Study 35007153 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel and Carboplatin (PC)
Number of subjects: 449
Study 35007153 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel and Ifosfamide (PI)
Number of subjects: 449
Study 33676296 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic lidocaine (1.5 mg kg−1 bolus, followed by 2 mg kg−1 h−1 infusion)
Number of subjects: 100
Study 33676296 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (identical volumes and rates)
Number of subjects: 100
Study 33676296 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic lidocaine
Number of subjects: 100
Study 33676296 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 100
Study 32770840 — intervention group
Group type: EXPERIMENTAL
Intervention: MgSO4 infusion (30 mg/kg loading dose followed by 10 mg/kg/hr continuous infusion)
Number of subjects: 40
Study 32770840 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (same loading and maintenance infusion rates as MgSO4)
Number of subjects: 40
Study 34904450 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone iodine protocol (Group A)
Number of subjects: 40
Study 34904450 — intervention group
Group type: COMPARATOR
Intervention: Surveillance without povidone iodine (Group B)
Number of subjects: 40
Study 32788274 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 min mindful breathing and standard care
Number of subjects: 40
Study 32788274 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 40
Study 34570024 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (AET)
Number of subjects: 19
Study 34570024 — intervention group
Group type: COMPARATOR
Intervention: Nonaerobic stretching and toning (SAT)
Number of subjects: 19
Study 34570024 — intervention group
Group type: COMPARATOR
Intervention: Healthy control (HC)
Number of subjects: 19
Study 33864331 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity simulation
Number of subjects: 59
Study 33864331 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual simulation
Number of subjects: 59
Study 33864331 — intervention group
Group type: EXPERIMENTAL
Intervention: Case study
Number of subjects: 59
Study 35556860 — intervention group
Group type: EXPERIMENTAL
Intervention: Jigsaw active learning technique
Number of subjects: 21
Study 35556860 — intervention group
Group type: EXPERIMENTAL
Intervention: Jigsaw active learning technique (using peer-created teaching materials)
Number of subjects: 21
Study 33852547 — intervention group
Group type: EXPERIMENTAL
Intervention: PM2.5 exposure
Number of subjects: 10035
Study 33852547 — intervention group
Group type: COMPARATOR
Intervention: Control group (matched controls)
Number of subjects: 10035
Study 33729371 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile application for cell phones (Intervention Group - IG)
Number of subjects: 88
Study 33729371 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - attended prenatal consultations without the application
Number of subjects: 88
Study 32573271 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-adjustable AFO (DA AFO)
Number of subjects: 20
Study 32573271 — intervention group
Group type: COMPARATOR
Intervention: Posterior leaf spring AFO (PLS AFO)
Number of subjects: 20
Study 32573271 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice with either AFO
Number of subjects: 20
Study 32573271 — intervention group
Group type: EXPERIMENTAL
Intervention: DA AFO
Number of subjects: 20
Study 32573271 — intervention group
Group type: COMPARATOR
Intervention: PLS AFO
Number of subjects: 20
Study 35886305 — intervention group
Group type: COMPARATOR
Intervention: Muay Thai
Number of subjects: 30
Study 35886305 — intervention group
Group type: EXPERIMENTAL
Intervention: Brazilian jiu-jitsu
Number of subjects: 30
Study 34721629 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with rehabilitation training
Number of subjects: 56
Study 34721629 — intervention group
Group type: COMPARATOR
Intervention: Sham procedures
Number of subjects: 56
Study 36384234 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile Palliative Care Link (mPCL)
Number of subjects: 49
Study 36384234 — intervention group
Group type: COMPARATOR
Intervention: Phone-contact POS collection
Number of subjects: 49
Study 35613785 — intervention group
Group type: EXPERIMENTAL
Intervention: Norming strategy for HIV testing
Number of subjects: 198
Study 35613785 — intervention group
Group type: COMPARATOR
Intervention: Standard strategy for HIV testing
Number of subjects: 198
Study 35613785 — intervention group
Group type: EXPERIMENTAL
Intervention: Norming strategy
Number of subjects: 198
Study 33874994 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile App (RheumaLive) for documenting disease activity
Number of subjects: 60
Study 33874994 — intervention group
Group type: COMPARATOR
Intervention: Paper-based PROMs (Hannover Functional Questionnaire/derived HAQ)
Number of subjects: 60
Study 32490976 — intervention group
Group type: EXPERIMENTAL
Intervention: Baerveldt glaucoma implant (250-mm2)
Number of subjects: 13
Study 32490976 — intervention group
Group type: COMPARATOR
Intervention: Mitomycin-augmented trabeculectomy
Number of subjects: 13
Study 35450683 — intervention group
Group type: EXPERIMENTAL
Intervention: Transradial access (TRA)
Number of subjects: 610
Study 35450683 — intervention group
Group type: COMPARATOR
Intervention: Transfemoral access (TFA)
Number of subjects: 610
Study 32077050 — intervention group
Group type: EXPERIMENTAL
Intervention: Planning intervention
Number of subjects: 200
Study 32077050 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200
Study 33416200 — intervention group
Group type: EXPERIMENTAL
Intervention: ipragliflozin
Number of subjects: 111
Study 33416200 — intervention group
Group type: EXPERIMENTAL
Intervention: sitagliptin
Number of subjects: 111
Study 32327091 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional flow reserve (FFR) measurement in non-infarct-related arteries (non-IRAs) after successful primary percutaneous coronary intervention
Number of subjects: 751
Study 35976662 — intervention group
Group type: EXPERIMENTAL
Intervention: High autistic traits (HAT)
Number of subjects: 0
Study 35976662 — intervention group
Group type: COMPARATOR
Intervention: Low autistic traits (LAT)
Number of subjects: 0
Study 32629295 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter InterAtrial Shunt Device (IASD)
Number of subjects: 608
Study 32629295 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 608
Study 34255327 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobility and stability exercises during warm-up for 10 weeks
Number of subjects: 32
Study 34255327 — intervention group
Group type: COMPARATOR
Intervention: Usual warm-up
Number of subjects: 32
Study 35786650 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Cued Recall test (ECR)
Number of subjects: 270
Study 35786650 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory Verbal Learning Test (AVLT)
Number of subjects: 270
Study 35786650 — intervention group
Group type: EXPERIMENTAL
Intervention: Logical Memory test (LM)
Number of subjects: 270
Study 35786650 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive testing based on the Uniform Data Set battery
Number of subjects: 270
Study 35786650 — intervention group
Group type: EXPERIMENTAL
Intervention: Rey-Osterrieth Complex Figure test
Number of subjects: 270
Study 35786650 — intervention group
Group type: EXPERIMENTAL
Intervention: Cued recall paradigm (CECR)
Number of subjects: 270
Study 32947549 — intervention group
Group type: EXPERIMENTAL
Intervention: Liberal postoperative activity recommendations (no limitations on physical activity)
Number of subjects: 95
Study 32947549 — intervention group
Group type: COMPARATOR
Intervention: Restricted postoperative activity recommendations (heavy lifting and high-impact activity prohibited)
Number of subjects: 95
Study 32757658 — intervention group
Group type: EXPERIMENTAL
Intervention: tPA dosing regimens for ultrasound-facilitated, catheter-directed fibrinolysis (8 mg/2 hours, 8 mg/4 hours, 12 mg/6 hours, and 24 mg/6 hours)
Number of subjects: 0
Study 32757658 — intervention group
Group type: EXPERIMENTAL
Intervention: tPA dosing regimens for ultrasound-facilitated, catheter-directed fibrinolysis
Number of subjects: 0
Study 36401325 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual Acupuncture (MA)
Number of subjects: 108
Study 36401325 — intervention group
Group type: COMPARATOR
Intervention: Sham Acupuncture (SA)
Number of subjects: 108
Study 32144974 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular oxygen-ozone therapy (O2O3)
Number of subjects: 42
Study 32144974 — intervention group
Group type: COMPARATOR
Intervention: Hyaluronic acid (HA)
Number of subjects: 42
Study 35721497 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasmalogen (2 mg per day)
Number of subjects: 40
Study 35721497 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 32988373 — intervention group
Group type: EXPERIMENTAL
Intervention: Single IV dose of fosaprepitant 150 mg
Number of subjects: 0
Study 32988373 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control regimen)
Number of subjects: 0
Study 36806623 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.9 mg of 0.1% oestradiol gel per day
Number of subjects: 78
Study 36806623 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 78
Study 35945496 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally-adapted Otago Exercise Program (OEP) delivered by community health representatives (CHR) for 6 months
Number of subjects: 200
Study 35945496 — intervention group
Group type: COMPARATOR
Intervention: Standard of care education-based fall risk management
Number of subjects: 200
Study 34323575 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight losers (n = 88)
Number of subjects: 231
Study 34323575 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight maintainers (n = 143)
Number of subjects: 231
Study 34323575 — intervention group
Group type: COMPARATOR
Intervention: Overall treatment group (including weight losers and maintainers)
Number of subjects: 231
Study 35433384 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg of oral magnesium powder
Number of subjects: 100
Study 35433384 — intervention group
Group type: COMPARATOR
Intervention: Starch powder (control)
Number of subjects: 100
Study 32761473 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined pars plana vitrectomy (PPV) and phacoemulsification (phaco)
Number of subjects: 68
Study 32761473 — intervention group
Group type: COMPARATOR
Intervention: PPV and deferred phaco
Number of subjects: 68
Study 34143954 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium infantis EVC001
Number of subjects: 0
Study 34143954 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 32386418 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative outcome expectancy (NOE) vignette
Number of subjects: 257
Study 32386418 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive outcome expectancy (POE) vignette
Number of subjects: 257
Study 32386418 — intervention group
Group type: COMPARATOR
Intervention: Standard care vignette
Number of subjects: 257
Study 33463492 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat-modified enteral nutrition (EN) suspension
Number of subjects: 141
Study 33428632 — intervention group
Group type: EXPERIMENTAL
Intervention: KRdc (Carfilzomib, Lenalidomide, Dexamethasone, Cyclophosphamide)
Number of subjects: 1056
Study 33428632 — intervention group
Group type: COMPARATOR
Intervention: Control (Tdc/Rdc - Thalidomide, Dexamethasone, Cyclophosphamide or Lenalidomide, Dexamethasone, Cyclophosphamide)
Number of subjects: 1056
Study 33428632 — intervention group
Group type: EXPERIMENTAL
Intervention: KRdc
Number of subjects: 1056
Study 34872040 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.2% plus dexamethasone 8 mg
Number of subjects: 60
Study 34872040 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine 0.2% plus placebo
Number of subjects: 60
Study 34176932 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous landiolol (started at 3 μg/min/kg dose and continued to a total of 50 mg; n=23)
Number of subjects: 47
Study 34176932 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=24)
Number of subjects: 47
Study 34176932 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous landiolol (n=23)
Number of subjects: 47
Study 33228846 — intervention group
Group type: EXPERIMENTAL
Intervention: Open urethroplasty
Number of subjects: 222
Study 33228846 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic urethrotomy
Number of subjects: 222
Study 33440062 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic-assisted surgery (da Vinci Xi system)
Number of subjects: 300
Study 33440062 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopy
Number of subjects: 300
Study 33158931 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted PCOS
Number of subjects: 0